Diagnosis: Mixed connective tissue disease
A 45-year-old woman presents with puffy hands, significant Raynaud phenomenon, and polyarthritis of several months' duration. Examination reveals edema of the hands, nailfold capillary changes, and symmetric joint swelling, raising suspicion for an underlying connective tissue disorder.
A 45-year-old woman presents with a 6-month history of puffy hands, intermittent episodes of color changes in her fingers due to cold exposure, and polyarthralgia affecting her wrists and fingers. On examination, her hands demonstrate marked edema, with visible nailfold capillary dilation and symmetrical joint swelling in the metacarpophalangeal joints. She also exhibits Raynaud’s phenomenon, characterized by pallor and cyanosis of the digits upon exposure to cold.Puffy hands with visible swelling and tenderness.Raynaud phenomenon evident with color changes in fingers.Symmetrical polyarthritis affecting multiple joints.Nailfold capillary changes observed during examination.No skin rashes noted during the initial assessment.
The patient reports that her symptoms began approximately 6 months ago, initially with swelling in her hands, followed by episodes of Raynaud phenomenon. She notes that stress and cold weather exacerbate her symptoms. She has no significant past medical history and denies any prior treatments for similar symptoms. Family history is positive for autoimmune diseases, including lupus in her sister. Social history is unremarkable; she works as an accountant and does not smoke or use recreational drugs.Onset: Symptoms started 6 months ago with hand swelling.Triggers: Symptoms worsen with stress and cold exposure.Prior treatments: No previous treatments for her current symptoms.Family history: Positive for autoimmune diseases, including lupus.Social history: Non-smoker, works as an accountant.
Acute / First-Line ManagementCalcium channel blockers (e.g., nifedipine 30 mg/day) are recommended for managing Raynaud's phenomenon.NSAIDs (e.g., ibuprofen 400 mg TID) can be used for polyarthritis management.Glucocorticoids may be considered for severe symptoms (e.g., prednisone 0.5-1 mg/kg/day).Workup and Diagnostic ConfirmationLaboratory tests: ANA and anti-RNP antibodies should be ordered to support the diagnosis.Nailfold capillaroscopy: This can reveal characteristic capillary changes associated with mixed connective tissue disease.Complete blood count and comprehensive metabolic panel: To assess for any associated hematological or organ involvement.Long-Term ManagementImmunosuppressive therapy: Consideration of low-dose methotrexate (e.g., 15 mg weekly) for polyarthritis.Regular follow-ups to monitor disease progression and treatment response.Patient education regarding lifestyle modifications to manage Raynaud’s phenomenon, such as warming techniques and stress management.
Lupus erythematosus: Characterized by a wide array of systemic symptoms; presence of malar rash and positive ANA can aid in differentiation.Scleroderma: Features include skin thickening and Raynaud's; nailfold capillary microscopy can help differentiate.Rheumatoid arthritis: Symmetrical joint involvement is common, but typically presents with morning stiffness and rheumatoid nodules.Sjogren's syndrome: Often presents with dryness; serological tests for anti-SSA/SSB antibodies can assist in diagnosis.Polymyositis: Muscle weakness and elevated muscle enzymes; not typically associated with Raynaud's phenomenon.Overlap syndrome: Features of multiple connective tissue diseases, often with serological markers of more than one condition.Vasculitis: Presents with systemic symptoms and may involve the skin; further workup for specific types may be warranted.
High-Yield PearlsMixed Connective Tissue Disease: Characterized by features of systemic lupus erythematosus, scleroderma, and polymyositis; early recognition is crucial for management.Raynaud’s Phenomenon: A hallmark symptom; management with calcium channel blockers can significantly improve quality of life.Nailfold Capillaroscopy: A valuable diagnostic tool; can reveal characteristic changes in microvasculature.Autoantibodies: The presence of anti-RNP antibodies is strongly associated with mixed connective tissue disease and aids in diagnosis.Patient Education: Essential for self-management of symptoms, particularly regarding Raynaud’s phenomenon.Recognizing the signs of mixed connective tissue disease early can lead to timely and effective management, improving patient outcomes.
Tags: MCTD, Raynaud